PROQR THERAPEUTICS EO-04 (0PQ) — Net Asset Momentum

Latest YoY growth as of December 2025: -44.2%

PROQR THERAPEUTICS EO-04 (0PQ) recorded a net asset momentum of -44.2% as of December 2025, with net assets of €49.37 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check 0PQ intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

YoY Momentum

-44.2%
Year-over-year

Current Net Assets

€49.37 Million
EUR · December 2025

Years of Data

5
2021 – 2025

Country

Germany
F

PROQR THERAPEUTICS EO-04 Net Asset Momentum (2021–2025)

This chart tracks PROQR THERAPEUTICS EO-04's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is -44.2%, with net assets of €49.37 Million EUR as of December 2025. Read 0PQ liabilities breakdown for a breakdown of total debt and financial obligations.

Annual Net Asset History for PROQR THERAPEUTICS EO-04 (2021–2025)

The table below shows the complete annual net asset history for PROQR THERAPEUTICS EO-04 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see PROQR THERAPEUTICS EO-04 (0PQ) market capitalisation.

Year Net Assets (EUR) Total Assets Total Liabilities YoY Momentum
2025 €49.37 Million €112.76 Million €63.38 Million ▼ -44.2%
2024 €88.56 Million €167.96 Million €79.40 Million ▲ +114.0%
2023 €41.39 Million €137.88 Million €96.49 Million ▼ -37.9%
2022 €66.68 Million €171.32 Million €104.64 Million ▼ -41.1%
2021 €113.23 Million €209.58 Million €96.35 Million